| Melissa Andrea Martinez Mateo, MD | |
|
2326 18th St Ste 210, Columbus, IN 47201-5362 | |
| (812) 372-8680 | |
| Not Available |
| Full Name | Melissa Andrea Martinez Mateo |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 18 Years |
| Location | 2326 18th St Ste 210, Columbus, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003124280 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Carle Foundation Hospital | Urbana, IL | Hospital |
| Columbus Regional Hospital | Columbus, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carle Health Care Incorporated | 3577515774 | 808 |
| Columbus Regional Health Physicians Llc | 1052612314 | 192 |
News Archive
Whether the problem is health, enemies, poverty or difficulty with aging, "Take your burden to the Lord and leave it there," suggested the late gospel musician Charles A. Tindley. But when it comes to easing symptoms of anxiety-related disorders, prayer doesn't have the same effect for everybody, according to a Baylor University researcher.
Extreme Networks, Inc. today introduced the Information Governance Engine, an optional add-on to the ExtremeManagement™ product portfolio, enabling CISOs and CIOs to establish and maintain a clinical baseline that demonstrates compliance with HIPAA and PCI standards for their mission-critical networks. The Information Governance Engine provides an automated scored assessment that empowers IT to understand how network changes may impact compliance.
In one such effort, Zhitong Chen et al., in a recent medRxiv* preprint paper find that by employing an efficient cold atmospheric plasma (CAP) with argon feed gas on different surfaces inactivates the infectious SARS-CoV-2 virus.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced a collaborative study with Almac's Diagnostics division for the Company's doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted conjugate compound, AEZS-108, aimed at determining LHRH receptor expression through the development of a companion diagnostic tool.
Pfizer announced today results of a survey the company recently sponsored that shows physicians are more likely to report side effects through an electronic health records (EHR) system, as compared to traditional paper methods. Nearly 60 percent of physicians who responded to the survey also agreed that adverse event reporting through an EHR system would improve patient care.
› Verified 6 days ago
| Entity Name | Cook County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588612832 PECOS PAC ID: 2860398088 Enrollment ID: O20031209000747 |
News Archive
Whether the problem is health, enemies, poverty or difficulty with aging, "Take your burden to the Lord and leave it there," suggested the late gospel musician Charles A. Tindley. But when it comes to easing symptoms of anxiety-related disorders, prayer doesn't have the same effect for everybody, according to a Baylor University researcher.
Extreme Networks, Inc. today introduced the Information Governance Engine, an optional add-on to the ExtremeManagement™ product portfolio, enabling CISOs and CIOs to establish and maintain a clinical baseline that demonstrates compliance with HIPAA and PCI standards for their mission-critical networks. The Information Governance Engine provides an automated scored assessment that empowers IT to understand how network changes may impact compliance.
In one such effort, Zhitong Chen et al., in a recent medRxiv* preprint paper find that by employing an efficient cold atmospheric plasma (CAP) with argon feed gas on different surfaces inactivates the infectious SARS-CoV-2 virus.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced a collaborative study with Almac's Diagnostics division for the Company's doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted conjugate compound, AEZS-108, aimed at determining LHRH receptor expression through the development of a companion diagnostic tool.
Pfizer announced today results of a survey the company recently sponsored that shows physicians are more likely to report side effects through an electronic health records (EHR) system, as compared to traditional paper methods. Nearly 60 percent of physicians who responded to the survey also agreed that adverse event reporting through an EHR system would improve patient care.
› Verified 6 days ago
| Entity Name | Southern Illinois Medical Services Nfp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770656837 PECOS PAC ID: 3678677390 Enrollment ID: O20070404000595 |
News Archive
Whether the problem is health, enemies, poverty or difficulty with aging, "Take your burden to the Lord and leave it there," suggested the late gospel musician Charles A. Tindley. But when it comes to easing symptoms of anxiety-related disorders, prayer doesn't have the same effect for everybody, according to a Baylor University researcher.
Extreme Networks, Inc. today introduced the Information Governance Engine, an optional add-on to the ExtremeManagement™ product portfolio, enabling CISOs and CIOs to establish and maintain a clinical baseline that demonstrates compliance with HIPAA and PCI standards for their mission-critical networks. The Information Governance Engine provides an automated scored assessment that empowers IT to understand how network changes may impact compliance.
In one such effort, Zhitong Chen et al., in a recent medRxiv* preprint paper find that by employing an efficient cold atmospheric plasma (CAP) with argon feed gas on different surfaces inactivates the infectious SARS-CoV-2 virus.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced a collaborative study with Almac's Diagnostics division for the Company's doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted conjugate compound, AEZS-108, aimed at determining LHRH receptor expression through the development of a companion diagnostic tool.
Pfizer announced today results of a survey the company recently sponsored that shows physicians are more likely to report side effects through an electronic health records (EHR) system, as compared to traditional paper methods. Nearly 60 percent of physicians who responded to the survey also agreed that adverse event reporting through an EHR system would improve patient care.
› Verified 6 days ago
| Entity Name | Carle Health Care Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154653947 PECOS PAC ID: 3577515774 Enrollment ID: O20100513000829 |
News Archive
Whether the problem is health, enemies, poverty or difficulty with aging, "Take your burden to the Lord and leave it there," suggested the late gospel musician Charles A. Tindley. But when it comes to easing symptoms of anxiety-related disorders, prayer doesn't have the same effect for everybody, according to a Baylor University researcher.
Extreme Networks, Inc. today introduced the Information Governance Engine, an optional add-on to the ExtremeManagement™ product portfolio, enabling CISOs and CIOs to establish and maintain a clinical baseline that demonstrates compliance with HIPAA and PCI standards for their mission-critical networks. The Information Governance Engine provides an automated scored assessment that empowers IT to understand how network changes may impact compliance.
In one such effort, Zhitong Chen et al., in a recent medRxiv* preprint paper find that by employing an efficient cold atmospheric plasma (CAP) with argon feed gas on different surfaces inactivates the infectious SARS-CoV-2 virus.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced a collaborative study with Almac's Diagnostics division for the Company's doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted conjugate compound, AEZS-108, aimed at determining LHRH receptor expression through the development of a companion diagnostic tool.
Pfizer announced today results of a survey the company recently sponsored that shows physicians are more likely to report side effects through an electronic health records (EHR) system, as compared to traditional paper methods. Nearly 60 percent of physicians who responded to the survey also agreed that adverse event reporting through an EHR system would improve patient care.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Andrea Martinez Mateo, MD Po Box 3988, Carbondale, IL 62902-3988 Ph: (618) 457-5200 | Melissa Andrea Martinez Mateo, MD 2326 18th St Ste 210, Columbus, IN 47201-5362 Ph: (812) 372-8680 |
News Archive
Whether the problem is health, enemies, poverty or difficulty with aging, "Take your burden to the Lord and leave it there," suggested the late gospel musician Charles A. Tindley. But when it comes to easing symptoms of anxiety-related disorders, prayer doesn't have the same effect for everybody, according to a Baylor University researcher.
Extreme Networks, Inc. today introduced the Information Governance Engine, an optional add-on to the ExtremeManagement™ product portfolio, enabling CISOs and CIOs to establish and maintain a clinical baseline that demonstrates compliance with HIPAA and PCI standards for their mission-critical networks. The Information Governance Engine provides an automated scored assessment that empowers IT to understand how network changes may impact compliance.
In one such effort, Zhitong Chen et al., in a recent medRxiv* preprint paper find that by employing an efficient cold atmospheric plasma (CAP) with argon feed gas on different surfaces inactivates the infectious SARS-CoV-2 virus.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced a collaborative study with Almac's Diagnostics division for the Company's doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted conjugate compound, AEZS-108, aimed at determining LHRH receptor expression through the development of a companion diagnostic tool.
Pfizer announced today results of a survey the company recently sponsored that shows physicians are more likely to report side effects through an electronic health records (EHR) system, as compared to traditional paper methods. Nearly 60 percent of physicians who responded to the survey also agreed that adverse event reporting through an EHR system would improve patient care.
› Verified 6 days ago
Vatsal Bajpai, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 2325 18th St Ste 130, Columbus, IN 47201 Phone: 812-379-2020 | |
Neil Amin, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5974 | |
Dr. Nandu Gourineni, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2325 18th St Ste 130, Columbus, IN 47201 Phone: 812-379-2020 Fax: 812-378-8267 | |
Lawrence Klein, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2325 18th St Ste 130, Columbus, IN 47201 Phone: 812-379-2020 Fax: 812-378-8267 | |
Chelsie Lynn Brady, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5974 Fax: 812-375-3203 | |
Brian M Kline, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 815 Schnier St, Columbus, IN 47201 Phone: 912-375-8810 |